BioAmber Net income (FY, 2017)-102.2 M
BioAmber EBIT (FY, 2017)-110 M
BioAmber Cash, 31-Dec-20174.6 M
BioAmber EV44.8 M

BioAmber Income Statement

Annual

USDFY, 2013FY, 2014FY, 2015FY, 2016FY, 2017

Revenue

2.7m1.5m2.2m

Revenue growth, %

(42%)41%

Sales and marketing expense

4.7m4.5m4.0m2.9m1.9m

General and administrative expense

9.8m10.7m10.6m9.5m12.4m

Operating expense total

14.5m15.1m14.6m12.4m14.3m

EBIT

41.2m35.2m38.5m(29.6m)(110.0m)

EBIT margin, %

1545%2282%1774%

Pre tax profit

33.7m47.2m41.2m(28.3m)(102.1m)

Income tax expense

102.8k75.4k(3.8k)25.6k

Net Income

33.8m(47.3m)41.2m(28.4m)(102.2m)

Quarterly

USDQ3, 2013Q1, 2014Q2, 2014Q3, 2014Q1, 2015Q2, 2015Q3, 2015Q1, 2016Q2, 2016Q3, 2016Q1, 2017Q2, 2017Q3, 2017

Revenue

866.5k350.7k414.6k469.3k367.2k1.5m2.5m

Cost of goods sold

655.2k

Gross profit

211.4k

Gross profit Margin, %

24%

Sales and marketing expense

1.1m1.1m1.7m954.2k1.2m1.1m920.7k1.2m583.5k479.4k641.5k560.7k458.0k

R&D expense

6.0m

General and administrative expense

2.3m2.9m2.9m2.4m2.6m3.0m2.2m2.6m3.0m1.8m4.9m2.9m2.3m

Operating expense total

3.4m4.0m4.6m3.4m3.8m4.1m9.1m3.8m3.6m2.2m5.5m3.5m2.8m

EBIT

5.8m7.5m10.4m8.3m8.5m10.9m9.9m8.5m(7.3m)(6.6m)(10.6m)(7.8m)(8.1m)

EBIT margin, %

675%2139%2503%1766%2304%583%(290%)

Pre tax profit

14.1m8.4m8.9m14.8m8.5m12.5m2.9m(6.7m)(1.4m)(8.8m)(7.9m)

Income tax expense

22.2k25.3k9.4k18.0k33.3k10.6k(28.7k)6.0k12.3k(28.7k)12.0k58.4k(21.2k)

Net Income

9.0m20.0m14.1m8.5m(9.0m)14.8m8.4m12.5m2.9m(6.7m)(1.4m)(8.9m)(7.8m)

BioAmber Balance Sheet

Annual

USDFY, 2013FY, 2014FY, 2015FY, 2016FY, 2017

Cash

83.7m7.0m16.2m4.6m

Accounts Receivable

755.0k476.9k978.6k986.9k4.9m

Inventories

2.4m1.8m1.7m4.5m4.8m

Current Assets

95.0m57.1m10.8m31.4m15.2m

PP&E

13.6m88.7m122.5m121.6m49.5m

Goodwill

692.8k625.4k625.4k625.4k

Total Assets

114.1m152.4m143.1m161.3m69.5m

Accounts Payable

7.1m15.8m6.0m6.2m

Current Liabilities

17.8m22.9m29.7m45.3m11.3m

Long-term debt

23.2m34.7m29.8m29.0m32.7m

Total Debt

23.2m29.8m29.0m32.7m

Total Liabilities

46.9m72.1m75.3m47.7m

Additional Paid-in Capital

177.3m220.5m258.8m280.8m352.3m

Retained Earnings

(161.5m)(198.3m)(220.8m)(318.9m)

Total Equity

67.1m57.5m

Debt to Assets Ratio

0.2 x0.2 x

Financial Leverage

1.7 x2.6 x

BioAmber Cash Flow

Annual

USDFY, 2013FY, 2014FY, 2015FY, 2016FY, 2017

Net Income

(33.8m)(47.3m)(41.2m)(28.4m)(102.2m)

Accounts Receivable

(158.8k)278.1k(581.1k)(5.0k)(3.7m)

Inventories

(521.1k)1.2m(8.1k)(2.8m)32.4k

Cash From Operating Activities

(27.5m)(22.5m)(32.2m)(37.6m)(29.8m)

Purchases of PP&E

(12.8m)

Cash From Investing Activities

(12.8m)(85.0m)(64.8m)(668.0k)(811.2k)

Long-term Borrowings

(25.0m)(16.1m)(15.3m)(19.0m)

Cash From Financing Activities

99.9m78.7m54.9m47.2m18.8m

Interest Paid

2.9m2.7m2.3m

BioAmber Ratios

USDY, 2017

EV/EBIT

-0.4 x

EV/CFO

-1.5 x
Report incorrect company information

BioAmber Employee Rating

2.75 votes
Culture & Values
2.1
Work/Life Balance
2.3
Senior Management
2.1
Salary & Benefits
2.4
Career Opportunities
2.3
Source